Wellgistics Health, Inc. (WGRX)
NASDAQ: WGRX · Real-Time Price · USD
0.0916
+0.0128 (16.24%)
May 13, 2026, 10:50 AM EDT - Market open
Wellgistics Health Revenue
In the year 2025, Wellgistics Health had annual revenue of $23.34M with 28.73% growth. Wellgistics Health had revenue of $1.67M in the quarter ending December 31, 2025, a decrease of -86.54%.
Revenue (ttm)
$23.34M
Revenue Growth
+28.73%
P/S Ratio
0.42
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.34M | 5.21M | 28.73% |
| Dec 31, 2024 | 18.13M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionWGRX News
- 1 hour ago - Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services - Accesswire
- 27 days ago - Wellgistics Health files $200M mixed securities shelf - TheFly
- 4 weeks ago - Wellgistics Health, Kare PharmTech execute joint venture - TheFly
- 4 weeks ago - Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives - Accesswire
- 7 weeks ago - Wellgistics enters LOI to evaluate potential acquisition of Neuritek - TheFly
- 7 weeks ago - Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders - Accesswire
- 7 weeks ago - Wellgistics Health converts $2M in deferred compensation equity at 20c per share - TheFly
- 7 weeks ago - Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share - Accesswire